Informed Girl

Research you can trust,
explained so you can act.

A health publication for people who want the science explained clearly, on skincare, reproductive systems, and genetic composition.

Informed Skin

Procedures, products, and the science behind them

65+ procedures scored
โ†’

Informed Hormones

Reproductive health, hormones, and wellness research

800+ studies reviewed
โ†’

Informed Genes

Environment, toxins, and long-term health

Coming soon

Global Research Index

Who is studying women's health?

Countries ranked by research investment, policy support, and peer-reviewed output.

Global Index

Women's Health Research Index

Ranks funding levels, active policy support, and peer-reviewed output. Updated April 2026.

1๐Ÿ‡ธ๐Ÿ‡ช
Swedenโ†‘

Highest per-capita women's health R&D spend globally

91
2๐Ÿ‡ณ๐Ÿ‡ฑ
Netherlandsโ†’

Home of Cochrane; world-leading hormonal research

88
3๐Ÿ‡ณ๐Ÿ‡ด
Norwayโ†‘

Gender equity mandated in all government research grants

86
4๐Ÿ‡ฉ๐Ÿ‡ฐ
Denmarkโ†’

National health registries power global epidemiology

85
5๐Ÿ‡ฆ๐Ÿ‡บ
Australiaโ†‘

NHMRC-funded; leads PCOS and reproductive guidelines

82
6๐Ÿ‡จ๐Ÿ‡ฆ
Canadaโ†’

CIHR maintains a dedicated women's health portfolio

80
7๐Ÿ‡ซ๐Ÿ‡ฎ
Finlandโ†’

Population registries; strong reproductive health output

78
8๐Ÿ‡ฉ๐Ÿ‡ช
Germanyโ†’

DFG-funded; major pharmaceutical and academic output

70
9๐Ÿ‡ฌ๐Ÿ‡ง
United Kingdomโ†“

UKRI budget cuts reducing research capacity since 2024

66
10๐Ÿ‡ซ๐Ÿ‡ท
Franceโ†’

INSERM active; leads nutrition and endocrinology research

64
11๐Ÿ‡จ๐Ÿ‡ญ
Switzerlandโ†’

SNSF stable; strength in thyroid and endocrine research

62
12๐Ÿ‡ณ๐Ÿ‡ฟ
New Zealandโ†’

PBRF-funded; strong reproductive policy framework

59
13๐Ÿ‡ฏ๐Ÿ‡ต
Japanโ†“

High publication volume but structural gender policy gaps

50
14๐Ÿ‡ฎ๐Ÿ‡น
Italyโ†’

Academic output strong; reproductive policy environment restrictive

43
15๐Ÿ‡บ๐Ÿ‡ธ
United Statesโ†“โ†“

NIH & Title X funding cut; DOGE halted key women's health grants

31

Score weights: research funding (40%) ยท active policy support (35%) ยท peer-reviewed output (25%). Reflects April 2026 political environment.

Global Index

Skincare & Dermatology Research Index

Ranks clinical trial output, cosmetic dermatology innovation, and ingredient safety research. Updated April 2026.

1๐Ÿ‡ฐ๐Ÿ‡ท
South Koreaโ†‘โ†‘

Global leader in cosmetic dermatology innovation and clinical trials

95
2๐Ÿ‡ซ๐Ÿ‡ท
Franceโ†’

INSERM-backed; deep expertise in cosmetic chemistry and formulation science

89
3๐Ÿ‡ฏ๐Ÿ‡ต
Japanโ†‘

Pioneered photoaging research; strong cosmeceutical regulatory framework

86
4๐Ÿ‡บ๐Ÿ‡ธ
United Statesโ†’

AAD and FDA-driven; largest volume of dermatology RCTs globally

84
5๐Ÿ‡ฉ๐Ÿ‡ช
Germanyโ†’

Beiersdorf and academic centers lead ingredient efficacy research

80
6๐Ÿ‡ฆ๐Ÿ‡บ
Australiaโ†‘

World-leading UV and skin cancer research; strong sunscreen science

78
7๐Ÿ‡ฌ๐Ÿ‡ง
United Kingdomโ†’

BAD and NHS dermatology; strong evidence-based aesthetic guidelines

75
8๐Ÿ‡ง๐Ÿ‡ท
Brazilโ†‘

Second-largest cosmetic surgery market; growing clinical research output

72
9๐Ÿ‡ฎ๐Ÿ‡น
Italyโ†’

Strong in injectable and laser research; active cosmetic dermatology societies

68
10๐Ÿ‡จ๐Ÿ‡ญ
Switzerlandโ†’

Home to major skincare R&D labs; strong regulatory environment

66
11๐Ÿ‡ธ๐Ÿ‡ช
Swedenโ†’

Karolinska-led dermatology research; focus on skin barrier science

63
12๐Ÿ‡ฎ๐Ÿ‡ณ
Indiaโ†‘โ†‘

Fast-growing dermatology research output; Ayurvedic integration studies

58
13๐Ÿ‡จ๐Ÿ‡ณ
Chinaโ†‘โ†‘

Rapidly expanding clinical trials; major cosmeceutical market growth

55
14๐Ÿ‡น๐Ÿ‡ญ
Thailandโ†‘

Growing aesthetic medicine hub; increasing clinical research capacity

48
15๐Ÿ‡ณ๐Ÿ‡ฌ
Nigeriaโ†‘

Emerging dermatology research; focus on melanin-rich skin science

35

Score weights: clinical trial volume (35%) ยท cosmetic dermatology innovation (30%) ยท ingredient safety research (20%) ยท regulatory framework (15%).

Weekly Briefings

Stay informed

Research summaries, ingredient deep-dives, and health insights, delivered thoughtfully.

No spam ยท Unsubscribe anytime